Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021632

Expand all

ERAXIS (ANIDULAFUNGIN)
50MG/VIAL Marketing Status: Prescription

Active Ingredient: ANIDULAFUNGIN
Proprietary Name: ERAXIS
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021632
Product Number: 001
Approval Date: Feb 17, 2006
Applicant Holder Full Name: VICURON PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ERAXIS (ANIDULAFUNGIN)
100MG/VIAL Marketing Status: Prescription

Active Ingredient: ANIDULAFUNGIN
Proprietary Name: ERAXIS
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 100MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021632
Product Number: 002
Approval Date: Nov 14, 2006
Applicant Holder Full Name: VICURON PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English